维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Luftner"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Nuclear matrix proteins as biomarkers for breast cancer显示文摘	Possinger K	2002	Exp Rev Mol Diagn2002，2，1：	1
2	Wireless infrared communications with edge position modulation for mobile devices显示文摘	Luftner T Kropl C Hagelauer R	2003	IEEE Transactions on Wireless Communications2003，10，2：	1
3	Upregulation of HER- 2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients显示文摘	Luftner D Jung A Schmid P	2003	Breast Cancer Res Treat2003，80，3：	1
4	Tumor typeM2 pyruvate kinase expression in advanced breast cancer显示文摘	Luftner D Meerharm J AkriC	2000	Anticancer Res2000，20，6：	1
5	Tumor type M2 pyruvate kinase expression in advanced breast cancer显示文摘	Luftner D Mesterharm J Akrivakis C	2000	Anticancer Res2000，20，6：	1
6	Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes显示文摘	Kummel S Eggemann H Luftner D	2006	Anticancer Res2006，26，2：	1
7	Nuclear matrix proteins as biomarkers for breast cancer显示文摘	Luftner D Possinger K	2002	Exp Rev Mol Diagn2002，2，1：	1
8	Tumor type M2 pyruvate kinase expression in advanced breast cancer显示文摘	Luftner D Mesterhann J Akrivakis C	2000	Anticancer Res2000，20，6：	1
9	Tumgr type M2 pyruvate kinase expression in advanced breast cancer 显示文摘	Luftner D Mesterharm J Akrivakis C	2000	Antieancer Res2000，20，6：	1
10	Nuclear matrix proteins as biomarkers for breast cancer显示文摘	Luftner D Possinger K	2002	Expert Rev Mol Diagn2002，2，1：	1
11	Nuclear matrix proteins as biomarkers for breast cancer显示文摘	Luftner D Possinger K	2002	Expert Rev Mol Diag2002，2，：	1
12	The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid显示文摘	Zamboni WC Luftner DI Egorin MJ	2001	Ann Oncol2001，12，1：	1
13	Gemcitabine for palliative treatment in metastatic breast cancer 显示文摘	Flath B Akrivakis C	1998	J Cancer Res Clin Oncol1998，124，：	1
14	Tumor type M2 pyruvate ki-nase expression in advanced breast cancer显示文摘	Luftner D Meerharm J Akri C		0，，6：	1
15	ADVIA Centaur HER-2/neu shows value in monitoring patients with metastatic breast cancer 显示文摘	Luftner D Cheli C Mickelson K	2004	Int J Biol Markers2004，19，3：	1
16	ADVIA Centaur HER-2/neu shows value in monitoring patients with metastatic breast cancer显示文摘	Luftner D Cheli C Mickelson K	2004	Int J Biol Markers2004，19，3：	1
17	Nuclear matrix proteins as biomarkers for breast cancer显示文摘	Luftner D Possinger K	2002	Expert Rev Mol Diagn2002，2，1：	1
18	Plasma levels of HER-2/neu, tumor tyPe M2 Pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer显示文摘	Luftner D Mazurek S Henschke P	2003	Anticancer Res2003，23，2：	1
19	Tumor type M2 pyruvate kinase expression in advanced breast cancer显示文摘	Luftner D Meerharm J Akri C	2000	Anticancer Res2000，20，6：	1
20	The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in eerebrospinal fluid 显示文摘	Zamboni WC Luftner DI Egorin M J	2001	Ann Oncol2001，12，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示